BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 29394540)

  • 1. [A Case of Recurrent Gastric Cancer with Grade 3 Proteinuria Caused by Ramucirumab plus Paclitaxel Therapy].
    Kimura Y; Makari Y; Mikami J; Hiraki Y; Kato H; Iwama M; Shiraishi O; Yasuda A; Shinkai M; Imano M; Imamoto H; Fujita J; Furukawa H; Yasuda T
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1080-1082. PubMed ID: 29394540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A Case of an Elderly Patient with Unresectable Gastric Cancer Treated by Paclitaxel and Ramucirumab].
    Kimura Y; Makari Y; Mikami J; Yoshimura J; Inoue T; Sawada G; Nakahira S; Yamamura J; Kamigaki S; Nakata K; Yamamoto T; Ikeda N; Tsujie M; Fujita J; Ohzato H
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):2404-2406. PubMed ID: 28133336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A Case of Gastric Cancer with Peritoneal Dissemination Effectively Treated with Ramucirumab and Paclitaxel].
    Seo S; Suzuki T; Misumi T; Tashiro H
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1305-1307. PubMed ID: 29394615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness and safety of ramucirumab plus paclitaxel chemotherapy in the treatment of advanced and recurrent gastric cancer.
    Kimura M; Usami E; Teramachi H; Yoshimura T
    J Oncol Pharm Pract; 2018 Sep; 24(6):403-411. PubMed ID: 28436252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective cohort study of nanoparticle albumin-bound paclitaxel plus ramucirumab versus paclitaxel plus ramucirumab as second-line treatment in patients with advanced gastric cancer.
    Okunaka M; Kotani D; Demachi K; Kawazoe A; Yoshino T; Kawasaki T; Shitara K
    BMC Cancer; 2020 Nov; 20(1):1111. PubMed ID: 33198652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical Experience of Ramucirumab for Treating Advanced Gastric Cancer].
    Kimura Y; Makari Y; Mikami J; Kamigaki S; Ikejima A; Fujii C; Sawada G; Nakahira S; Yamamura J; Nakata K; Yamamoto T; Ikeda N; Tsujie M; Fujita J; Ohzato H
    Gan To Kagaku Ryoho; 2016 Oct; 43(10):1193-1196. PubMed ID: 27760936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial.
    Wilke H; Muro K; Van Cutsem E; Oh SC; Bodoky G; Shimada Y; Hironaka S; Sugimoto N; Lipatov O; Kim TY; Cunningham D; Rougier P; Komatsu Y; Ajani J; Emig M; Carlesi R; Ferry D; Chandrawansa K; Schwartz JD; Ohtsu A;
    Lancet Oncol; 2014 Oct; 15(11):1224-35. PubMed ID: 25240821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A recurrent gastric cancer with peritoneal metastasis 15 years after distal gastrectomy successfully treated with S-1 and weekly intravenous and intraperitoneal injections of Paclitaxel].
    Iwai N; Wakabayashi N; Matsumoto N; Morita Y; Tanaka N; Yoriki H; Fujii K; Takada R; Takaya H; Masuzawa A; Takami S; Kataoka K
    Gan To Kagaku Ryoho; 2015 Mar; 42(3):351-4. PubMed ID: 25812506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of advanced gastric cancer with peritoneal metastasis that responded to paclitaxel plus 5-FU therapy].
    Kobayashi D; Honda I; Kato T; Mori M
    Gan To Kagaku Ryoho; 2006 Sep; 33(9):1313-6. PubMed ID: 16969032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of curatively resected schirrous gastric cancer effectively treated by combined chemotherapy of weekly paclitaxel (PTX) and CDDP].
    Nagata N; Nakayama Y; Matsumoto K; Inoue Y; Shibao K; Higure A; Hirata K; Itoh H
    Gan To Kagaku Ryoho; 2005 Dec; 32(13):2101-4. PubMed ID: 16352936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Three Patients with Gastric Cancer Who Underwent Surgery during Ramucirumab Treatment].
    Omori H; Kawai S; Makuuchi R; Irino T; Tokunaga M; Tanizawa Y; Bando E; Kawamura T; Yasui H; Terashima M
    Gan To Kagaku Ryoho; 2017 Nov; 44(11):1021-1023. PubMed ID: 29138380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A Case of Port Site Recurrence after Laparoscopic Distal Gastrectomy for Advanced Gastric Cancer].
    Fujita S; Ohki S; Kase K; Yamauchi N; Chida S; Hayase S; Sakamoto W; Monma T; Takawa M; Ohtake T; Kono K; Takenoshita S
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):1502-1504. PubMed ID: 28133037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of recurrent gastric cancer with peritoneal dissemination responding to doxifluridine/paclitaxel combination chemotherapy as third-line treatment].
    Yagi Y; Ichikawa K; Takahashi K; Okuda N
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):261-3. PubMed ID: 17301540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of paclitaxel-resistant recurrent gastric cancer responsive to S-1 plus docetaxel].
    Nishikawa K; Iwase K; Aono T; Yoshida H; Nomura M; Tamagawa H; Matsuda C; Deguchi T; Kawada J; Higashi S; Deguchi K; Noguchi Y; Okumura Y; Nomura M; Fushimi H; Takagi M; Fukui A; Fujitani K; Endo S; Tanaka Y
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2259-61. PubMed ID: 24394078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites.
    Kitayama J; Ishigami H; Yamaguchi H; Yamashita H; Emoto S; Kaisaki S; Watanabe T
    Ann Surg Oncol; 2014 Feb; 21(2):539-46. PubMed ID: 23975319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Successful management with S-1 of recurrent gastric cancer after adjuvant chemotherapy with paclitaxel/UFT].
    Tokunaga Y; Sasaki H; Saito T
    Gan To Kagaku Ryoho; 2010 Apr; 37(4):703-6. PubMed ID: 20414030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-World Effectiveness and Safety of Ramucirumab as a Second-Line Treatment for Patients with Unresectable Advanced or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma in Japan and South Korea: A Systematic Literature Review.
    Zhang X; Zhou L; Zhou C; Shen L
    Adv Ther; 2024 Jun; 41(6):2112-2132. PubMed ID: 38619719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of complete remission of carcinomatous ascites refractory for TS-1 monotherapy treated with TS-1 plus paclitaxel combined therapy for gastric cancer].
    Imamura H; Furukawa H; Kishimoto T; Miyazaki Y; Yamamoto K; Ohshiro R; Ohta K; Nakata Y; Kamigaki S; Kondo M; Takemoto H; Fujimi S; Nakayama T; Fukunaga M; Ohsato H; Tatsuta M
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1900-3. PubMed ID: 17212141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective study of the safety and efficacy of paclitaxel plus ramucirumab in patients with advanced or recurrent gastric cancer with ascites.
    Matsumoto H; Kawazoe A; Shimada K; Fukuoka S; Kuboki Y; Bando H; Kojima T; Ohtsu A; Yoshino T; Doi T; Shitara K
    BMC Cancer; 2018 Jan; 18(1):120. PubMed ID: 29385993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The Clinical Effect of Ramucirumab in the Treatment of Advanced Gastric Cancer in Our Hospital].
    Kenno S; Takahashi S; Noguchi K; Yamagami H; Ishizu H; Takahashi M
    Gan To Kagaku Ryoho; 2018 Jan; 45(1):79-81. PubMed ID: 29362314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.